by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Dementia
Alzheimer’s &Dementia, Volume 22, Issue 9, September 2026. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-Dementia...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Neuropsychology (general)
. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: | September 2, 2026 Neuro-General Previous Page
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Neuroscience
Nature Neuroscience, Published online: 02 September 2026; doi:10.1038/s41593-026-02421-xThis study shows that addictive drugs hijack mitochondrial Ca2+-dependent bioenergetics in reward circuits to drive pathological dopamine release, identifying mitochondrial calcium...
by Clinical Neuropsychologist Online | Wednesday, September 2, 2026 | Neuroscience
Nature Neuroscience, Published online: 02 September 2026; doi:10.1038/s41593-026-02414-wThis study shows that glutamate concentration at synapses can dynamically reshape how synaptic AMPA receptors pass current and calcium. This reveals a rapid way that synapses tune...
by Clinical Neuropsychologist Online | Tuesday, September 1, 2026 | Dementia
Abstract INTRODUCTION Plasma phosphorylated tau (p-tau), particularly p-tau217, is a highly specific biomarker of Alzheimer’s disease (AD) pathology. However, plasma p-tau217 can be elevated in rare non-AD conditions. Brain-derived (BD) p-tau217 may reduce these...
